文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

消除孕产妇和新生儿破伤风的投资案例

An investment case for maternal and neonatal tetanus elimination.
PubMed 文献 · Vaccine · 2020-01-21

全球尚有13个国家未消除孕产妇和新生儿破伤风。

核心结论

  • 通过显著财政投入、高度优先重视和强有力的政治意愿,可以消除孕产妇和新生儿破伤风。
  • 尽管覆盖难以触及人群需大量费用,但出于卫生公平应实现消除目标,并将显著促进联合国可持续发展目标的实现。

研究设计与样本

  • 针对尚未消除孕产妇和新生儿破伤风的13个国家(阿富汗、安哥拉、中非共和国、刚果民主共和国、几内亚、马里、尼日利亚、巴基斯坦、巴布亚新几内亚、索马里、南苏丹、苏丹和也门)估算三年内实现消除的成本。
  • 成本估算涵盖:使用标准含破伤风类毒素疫苗和TT-Uniject™在高风险地区针对育龄妇女的疫苗接种运动;在产前保健诊所向孕妇提供的额外接种;清洁分娩和脐带护理推广;新生儿破伤风监测强化;验证活动。
  • 预测可避免的死亡以评估实现消除的成本效果。

主要发现

  • 每避免一例死亡花费2900美元,每获得一个生命年花费45美元。

关键数值与推荐

  • 消除目标为每个地区每年每1000活产中新生儿破伤风病例少于1例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Globally, 13 countries have yet to eliminate maternal and neonatal tetanus. While efforts have improved access to tetanus toxoid containing vaccines (TTCVs) and increased clean delivery practices, reaching elimination targets (<1 case of neonatal tetanus per 1000 live births per district per year) may require significant resources to reach the remaining high risk and hard-to-reach districts. METHODS: We estimated the cost to achieve maternal and neonatal tetanus elimination (MNTE) in three years in the remaining 13 countries: Afghanistan, Angola, Central African Republic, Democratic Republic of the Congo, Guinea, Mali, Nigeria, Pakistan, Papua New Guinea, Somalia, South Sudan, Sudan, and Yemen. Costs were estimated for: (1) vaccination campaigns using standard TTCVs and TT-Uniject™ targeting women of reproductive age in high risk areas, (2) additional vaccinations delivered to pregnant women at antenatal care (ANC) clinics, (3) clean delivery and umbilical cord care promotion, (4) neonatal tetanus surveillance strengthening, and (5) validation activities. We forecasted the averted mortality to assess the cost-effectiveness of achieving MNTE. RESULTS: It will cost an estimated US$197.7 million to realize MNTE over three years. These costs include $161.4 million for vaccination campaigns, $6.1 million for routine vaccination during ANC, $23.3 million for promotion of clean delivery practices, $4 million for surveillance, and $3 million for validation of MNTE. Achieving MNTE will avert approximately 70,000 neonatal deaths over ten years of vaccine protection, resulting in approximately 4.4 million life years gained. It will cost $2,900 per death averted and $45 per life year gained. CONCLUSION: Maternal and neonatal tetanus can be eliminated with significant financial investment, high prioritization, and strong political will. While substantial costs must be incurred to reach hard-to-reach populations, MNTE should be accomplished as a matter of health equity, and will significantly contribute to reaching the United Nations' Sustainable Development Goals.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Laing SK, Griffiths U, Raza AA, et al. An investment case for maternal and neonatal tetanus elimination. Vaccine. 2020. PMID: 31980197. doi:10.1016/j.vaccine.2019.11.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。